Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume -, Issue -, Pages jnnp-2020-322941
Publisher
BMJ
Online
2020-05-06
DOI
10.1136/jnnp-2020-322941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Abbott Architect ® , Siemens Immulite ® , and Diasorin Liaison ® for determination of Epstein–Barr virus serological diagnosis
- (2018) Catherine François et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
- (2017) René M. Gieß et al. PLoS One
- Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016
- (2017) Grégoire Fourcade et al. PLoS One
- Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update
- (2016) Kassandra Munger et al. SEMINARS IN NEUROLOGY
- Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
- (2015) Lazaros Belbasis et al. LANCET NEUROLOGY
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Performance of the Architect EBV Antibody Panel for Determination of Epstein-Barr Virus Infection Stage in Immunocompetent Adolescents and Young Adults with Clinical Suspicion of Infectious Mononucleosis
- (2014) Alvaro Guerrero-Ramos et al. Clinical and Vaccine Immunology
- Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition
- (2013) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- Are there Epstein–Barr virus seronegative patients with multiple sclerosis?
- (2013) Katrin Deuschle et al. Multiple Sclerosis Journal
- Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
- (2013) Dana Horakova et al. PLoS One
- Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis
- (2013) Yahya H. Almohmeed et al. PLoS One
- Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students
- (2012) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis
- (2012) J. Pakpoor et al. Multiple Sclerosis Journal
- The initiation and prevention of multiple sclerosis
- (2012) Alberto Ascherio et al. Nature Reviews Neurology
- Primary infection with the epstein-barr virus and risk of multiple sclerosis
- (2010) Lynn I. Levin et al. ANNALS OF NEUROLOGY
- An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
- (2010) Adam E. Handel et al. PLoS One
- The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis
- (2009) Douglas S. Goodin PLoS One
- Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern
- (2008) Massimo De Paschale et al. JOURNAL OF MEDICAL VIROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More